GO:0036217 dGTP diphosphatase activity: Mechanism & Genes

dGTP diphosphatase activity (GO:0036217) is a molecular function that catalyzes the reaction dGTP + H2O = dGMP + H+ + diphosphate. This activity belongs to the broader class of nucleotide pyrophosphatases that cleave the alpha-beta phosphoanhydride bond of deoxynucleoside triphosphates, releasing a monophosphate and pyrophosphate. By removing dGTP from the nucleotide pool, this activity directly impacts DNA replication fidelity, repair, and the balance of deoxynucleotide triphosphates (dNTPs) within cells. Researchers study dGTP diphosphatase activity because dGTP is a substrate for DNA polymerases and its misincorporation or imbalance can lead to mutagenesis and genome instability. The enzyme activity also plays a role in the metabolism of nucleoside analog prodrugs, as highlighted by studies on fluorocyclopentenylcytosine (RX-3117) resistance, where DCTPP1 and MTH1 influence drug sensitivity. In mitochondria, deoxynucleoside kinase activities are tightly regulated to supply dNTPs for mitochondrial DNA synthesis, and perturbations in this regulation can affect mitochondrial function. Understanding dGTP diphosphatase activity therefore bridges basic nucleotide metabolism, DNA replication, and therapeutic resistance. The following sections define the term, outline its mechanism, list key genes, and describe experimental models and methods for investigating this activity in human cells.

dGTP diphosphatase activity (GO:0036217) is defined as the catalysis of the reaction: dGTP + H2O = dGMP + H+ + diphosphate. In other words, it is an enzyme activity that hydrolyzes 2'-deoxyguanosine 5'-triphosphate (dGTP) into 2'-deoxyguanosine 5'-monophosphate (dGMP) and pyrophosphate (diphosphate), releasing a proton. This activity is synonymous with 2'-deoxyguanosine 5'-triphosphate diphosphohydrolase and dGTP pyrophosphatase activity. It belongs to the molecular_function ontology aspect and is distinct from DNA polymerase activity, which incorporates dGTP into DNA, and from dGTPase activity, which may release different products.

dGTP diphosphatase activity is important because it controls the intracellular concentration of dGTP, a key substrate for DNA replication and repair. Imbalances in dNTP pools can cause misincorporation, mutagenesis, and cell death, and are exploited by nucleoside analog chemotherapies. The activity also intersects with mitochondrial nucleotide metabolism, where deoxynucleoside kinases regulate dNTP supply for mitochondrial DNA synthesis. Thus, understanding dGTP diphosphatase activity informs basic mechanisms of genome maintenance and therapeutic strategies in cancer and mitochondrial disorders.

The following genes and proteins are directly or indirectly linked to dGTP diphosphatase activity, nucleotide pool regulation, and related metabolic pathways.

dGTP diphosphatase activity is regulated at multiple levels. Substrate availability of dGTP directly influences the reaction rate, as the enzyme requires dGTP for catalysis. The presence of RNA can modulate the moonlighting dGTP diphosphatase activity of Klenow DNA polymerase, suggesting that nucleic acid interactions can regulate this function. In mitochondria, deoxynucleoside kinase activities that supply dNTP precursors are regulated in response to cellular energy states and developmental signals, indirectly affecting dGTP levels and diphosphatase activity. Additionally, in cancer cells, the expression of DCTPP1 and MTH1, which are involved in nucleotide sanitation, can alter sensitivity to nucleoside analogs, indicating that these regulatory networks impact dGTP-related metabolism.

dGTP diphosphatase activity and related nucleotide sanitation enzymes influence the efficacy of nucleoside analog drugs. In lung cancer cells resistant to fluorocyclopentenylcytosine (RX-3117), the expression and activity of DCTPP1 and MTH1 were evaluated, revealing potential cross-resistance patterns. These enzymes help maintain nucleotide pool balance, and their modulation can affect drug incorporation into DNA. Thus, dGTP diphosphatase-like activities may contribute to chemoresistance and represent potential targets for combination therapies.

Mitochondrial deoxynucleoside kinase activities, which supply dNTPs for mitochondrial DNA synthesis, are regulated in rat liver mitochondria. Perturbations in these pathways can lead to mitochondrial DNA depletion syndromes and other mitochondrial disorders. Although direct links between dGTP diphosphatase activity and specific mitochondrial diseases are not yet fully established, the role of dGTP in mitochondrial nucleotide pools suggests that dysregulation could contribute to mitochondrial dysfunction.

Imbalanced dNTP pools, including excess dGTP, can cause misincorporation during DNA replication and lead to mutagenesis. dGTP diphosphatase activity helps sanitize the nucleotide pool by removing excess dGTP, thereby reducing the risk of replication errors. Moonlighting activities of DNA polymerases, such as the dGTP diphosphatase activity of Klenow fragment in the presence of RNA, may also influence replication fidelity. Defects in such activities could contribute to genome instability and cancer predisposition.

Direct measurement of dGTP diphosphatase activity can be performed using purified enzymes or cell lysates incubated with dGTP, followed by detection of dGMP and diphosphate products via HPLC, mass spectrometry, or colorimetric assays. These methods allow kinetic characterization and inhibitor testing. The moonlighting activity of Klenow DNA polymerase in the presence of RNA was demonstrated using such biochemical approaches.

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) enables quantification of dNTPs and their monophosphate derivatives in cells. This method can reveal changes in dGTP and dGMP levels upon genetic manipulation of dGTP diphosphatase candidates. It is particularly useful for studying drug resistance mechanisms, as shown in RX-3117-resistant lung cancer cells where DCTPP1 and MTH1 were evaluated.

Genome-wide CRISPR knockout or activation screens can identify genes that modulate sensitivity to nucleoside analogs or affect dNTP homeostasis. Such screens can uncover synthetic lethal interactions with dGTP diphosphatase loss and highlight pathways that compensate for its absence. Libraries targeting nucleotide metabolism genes are especially relevant.

Mitochondrial deoxynucleoside kinase activities can be measured in isolated mitochondria or permeabilized cells using radiolabeled substrates. These assays help assess the impact of dGTP diphosphatase manipulation on mitochondrial dNTP supply and mitochondrial DNA replication. Oxygen consumption and membrane potential measurements can complement these studies.

Researchers studying dGTP diphosphatase activity-related genes often need to determine whether a candidate gene is causally involved in nucleotide pool regulation, drug resistance, or mitochondrial function. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of dGTP diphosphatase candidates.

dGTP diphosphatase activity (GO:0036217) is a critical molecular function that maintains dGTP homeostasis, impacting DNA replication fidelity, mitochondrial nucleotide supply, and sensitivity to nucleoside analog drugs. Its study bridges basic nucleotide metabolism with clinical challenges such as chemoresistance and mitochondrial disorders. Leveraging CRISPR-based models and advanced biochemical methods will continue to uncover the regulatory networks and therapeutic potential of this activity.